Nephros Inc (NEPH)
Nephros Launches "Nephros Water Institute"
MAIA Biotechnology Inc. (MAIA)
MAIA’s Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates
National Research (NRC)
The Latest from NRC Health | Share your story at HUB26, advance equity and experience in pediatric care, and so much more!
Aurora Cannabis Inc. (ACB)
Aurora Expands Leading Portfolio of High-Potency Medical Flower Products in Poland
Heart Test Laboratories Inc (HSCSW)
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1
Illumina Inc (ILMN)
Illumina, Inc. - Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme’s Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually
Bicycle Therapeutics (BCYC)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bicycle Therapeutics plc - BCYC
Anavex Life Sciences Corp. (AVXL)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
Alvotech (ALVO)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO
Soleno Therapeutics Inc. (SLNO)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO